oral semaglutide vs injection Injectable for Weight Loss Choosing Oral vs. Injectable Semaglutide

About ATTAIN-MAINTAIN trial and ATTAIN clinical trial program ATTAIN-MAINTAIN (NCT06584916) was a 52-week, Phase 3, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of once-daily orforglipron versus placebo for maintenance of body weight reduction in adults with obesity or overweight with weight-related comorbidities who previously completed the SURMOUNT-5 head-to-head trial

FDA warnings for semaglutide salts FDA warns against using semaglutide in any form other than the regular version, including when its a salt

The gel, when it hits your stomach, expands and triggers stretch receptors that tell your brain youre full

There were also lower risks of alcohol (HR, 0.346) or substance (HR, 0.510) use disorders